Evidence map›Paper›PMID 32950304›Full record

ArticleVaccine2020

Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization.

Heather M Scobie, Michael Edelstein, Edward Nicol, Ana Morice, Nargis Rahimi, Noni E MacDonald, Carolina M Danovaro-Holliday, Jaleela Jawad, SAGE Working Group on Immunization and Surveillance Data Quality and Use

Abstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. From Disparity to Integration: Transforming India's Immunization Strategy through Private Sector Engagement.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Immunization data management practices and data quality in Ethiopia.Archives of public health = Archives belges de sante publique · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. An Innovative Youth-Friendly Electronic Questionnaire to Identify Mental, Sexual and Reproductive Health Risks: A Validation Study of the Total Teen Assessment.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heather M ScobieCenters for Disease Control and Prevention, Atlanta, USA. Electronic address: hscobie@cdc.gov.
Michael EdelsteinPublic Health England (PHE), London, United Kingdom. Electronic address: Michael.Edelstein@doctors.org.uk.
Edward NicolBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa; Health System and Public Health Division, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. Electronic address: edward.nicol@mrc.ac.za.
Ana MoriceIndependent Consultant, San Jose, Costa Rica.
Nargis RahimiShifo Foundation, Sweden. Electronic address: nargis@shifo.org.
Noni E MacDonaldDalhousie University, IWK Health Centre, Canada. Electronic address: noni.macdonald@dal.ca.
Carolina M Danovaro-HollidayWorld Health Organization, Geneva, Switzerland. Electronic address: danovaroc@who.int.
Jaleela JawadPublic Health Directorate, Ministry of Health, Bahrain.
SAGE Working Group on Immunization and Surveillance Data Quality and Use

Funding

World Health Organization 001
6 · The paper itself

Abstract

Concerns about the quality and use of immunization and vaccine-preventable disease (VPD) surveillance data have been highlighted on the global agenda for over two decades. In August 2017, the Strategic Advisory Group of Experts (SAGE) established a Working Group (WG) onthe Quality and Use of Global Immunization and Surveillance Data to review the current status and evidence to make recommendations, which were presented to SAGE in October 2019. The WG synthesized evidence from landscape analyses, literature reviews, country case-studies, a data triangulation analysis, as well as surveys of experts. Data quality (DQ) was defined as data that are accurate, precise, relevant, complete, and timely enough for the intended purpose (fit-for-purpose), and data use as the degree to which data are actually used for defined purposes, e.g., immunization programme management, performance monitoring, decision-making. The WG outlined roles and responsibilities for immunization and surveillance DQ and use by programme level. The WG found that while DQ is dependent on quality data collection at health facilities, many interventions have targeted national and subnational levels, or have focused on new technologies, rather than the people and enabling environments required for functional information systems. The WG concluded that sustainable improvements in immunization and surveillance DQ and use will require efforts across the health system - governance, people, tools, and processes, including use of data for continuous quality improvement (CQI) - and that the approaches need to be context-specific, country-owned and driven from the frontline up. At the country level, major efforts are needed to: (1) embed monitoring DQ and use alongside monitoring of immunization and surveillance performance, (2) increase workforce capacity and capability for DQ and use, starting at the facility level, (3) improve the accuracy of immunization programme targets (denominators), (4) enhance use of existing data for tailored programme action (e.g., immunization programme planning, management and policy-change), (5) adopt a data-driven CQI approach as part of health system strengthening, (6) strengthen governance around piloting and implementation of new information and communication technology tools, and (7) improve data sharing and knowledge management across areas and organizations for improved transparency and efficiency. Global and regional partners are requested to support countries in adopting relevant recommendations for their setting and to continue strengthening the reporting and monitoring of immunization and VPD surveillance data through processes periodic needs assessment and revision processes. This summary of the WG's findings and recommendations can support "data-guided" implementation of the new Immunization Agenda 2030.

Indexed as

Immunization ProgramsResearch ReportGovernment ProgramsHumansImmunizationVaccinationData qualityData useImmunizationInformation systemsSurveillanceVaccinationVaccination coverageVaccine-preventable disease

Identifiers

PMID32950304
PMCPMC7573705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.